Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
7.85
-1.04 (-11.70%)
At close: Aug 15, 2025, 3:59 PM
8.02
2.17%
After-hours: Aug 15, 2025, 07:53 PM EDT
Cyclacel Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.28K | 3.45M | 3.14M | 2.98M | 6M | 2.8M | 3.38M | 5.94M | 10.16M | 11.44M | 18.34M | 23.71M | 29.08M | 29.64M | 36.56M | 40.22M | 43.64M | 47.78M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 412K | 413K | 413K | 1.24M | 1.26M | 1.26M | 1M | 2.92M | 2.92M | 2.92M | 3.06M | 2.98M | 1.55M | 1.51M | n/a | n/a |
Receivables | n/a | n/a | 237K | 1.62M | 974K | 1.34M | 2.93M | 2.53M | 1.95M | 6.12M | 4.66M | 2.79M | 2M | 6.03M | 3.73M | 2.51M | 1.59M | 2.14M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 577K | -2.51M | 836K | -2.01M |
Other Current Assets | 108.00 | 194K | 300K | 309K | 300K | 365K | 341K | 1.95M | 2.19M | 595K | 426K | 170K | 79K | 239K | -498K | 2.63M | -694K | 2.11M |
Total Current Assets | 4.38K | 3.71M | 3.67M | 4.91M | 7.71M | 4.83M | 7.44M | 11.11M | 15.29M | 18.97M | 24.41M | 27.91M | 32.08M | 36.58M | 40.94M | 43.38M | 46.2M | 50.46M |
Property-Plant & Equipment | 18.00 | 20K | 7K | 55K | 70K | 86K | 102K | 125K | 148K | 170K | 174K | 190K | 209K | 72K | 94K | 115K | 131K | 1.35M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 18.00 | 20K | 419K | 468K | 483K | 1.33M | 1.36M | 1.38M | 1.15M | 3.09M | 3.09M | 3.11M | 3.27M | 3.05M | 1.65M | 1.62M | 131K | 1.35M |
Total Assets | 4.4K | 3.73M | 4.09M | 5.38M | 8.19M | 6.17M | 8.8M | 12.5M | 16.44M | 22.06M | 28.05M | 31.02M | 35.35M | 39.63M | 42.59M | 45M | 46.33M | 51.82M |
Account Payables | 221.00 | 114K | 4.6M | 4.13M | 4.74M | 5.2M | 3.54M | 1.57M | 2.17M | 2.51M | 2.56M | 983K | 2.21M | 2.85M | 2.12M | 1.51M | 1.2M | 871K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 760.00 | 17K | 283K | 332K | 395K | 296K | 380K | 356K | 234K | 223K | 326K | 172K | 558K | 118K | 753K | 125K | 264K | 398K |
Total Current Liabilities | 760.00 | 663K | 6.27M | 6.35M | 7.19M | 8.35M | 8.16M | 8.15M | 6.75M | 7.34M | 7.51M | 4.35M | 5.03M | 6.2M | 5.41M | 3.59M | 3.12M | 2.77M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 10.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 10.00 | 9K | n/a | n/a | 5K | 21K | 37K | 52K | 66K | 80K | 106K | 107K | 113K | 15K | 30K | 44K | n/a | 996K |
Total Liabilities | 770.00 | 672K | 6.27M | 6.35M | 7.19M | 8.37M | 8.2M | 8.2M | 6.81M | 7.42M | 7.62M | 4.46M | 5.14M | 6.22M | 5.44M | 3.63M | 3.12M | 3.77M |
Total Debt | n/a | 9K | n/a | n/a | 5K | 21K | 37K | 52K | 66K | 80K | 106K | 107K | 113K | 15K | 30K | 44K | n/a | 996K |
Common Stock | n/a | 204K | 9K | 2K | 2K | 1K | 1K | 12K | 4.5M | 4.5M | 1K | 4.5M | 11K | 10K | 10K | 10K | 9K | 9K |
Retained Earnings | -441.78K | -440.46M | -439.49M | -436.44M | -434.49M | -431.23M | -428.28M | -423.01M | -417.41M | -411.96M | -405.73M | -398.74M | -393.64M | -389.07M | -384.53M | -379.66M | -374.68M | -369.55M |
Comprehensive Income | n/a | 1K | -891K | -1.03M | -915K | -898K | -908K | -1.17M | -1.1M | -1.22M | -1.32M | -1.75M | -1.28M | -823K | -748K | -753K | -658K | -730K |
Shareholders Equity | 3.63K | 3.06M | -2.17M | -970K | 999K | -2.21M | 607K | 4.3M | 9.63M | 14.64M | 20.43M | 26.56M | 30.21M | 33.41M | 37.69M | 41.36M | 43.22M | 48.05M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |